Angiotensin-converting enzyme 2: The first decade

International Journal of Hypertension

Volumn 2012, Issue , 2012, Pages

  Clarke, Nicola E ^a   Turner, Anthony J ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AMINO ACID TRANSPORTER; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ANGIOTENSIN CONVERTING ENZYME 2; ANGIOTENSIN DERIVATIVE; ANGIOTENSIN I; ANGIOTENSIN[1-7]; ANGIOTENSIN[1-9]; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FREE RADICAL; GELATINASE A; GELATINASE B; GLUCOSE; INTERLEUKIN 6; SMALL INTERFERING RNA; STREPTOZOCIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACE GENE; AMINO ACID SUBSTITUTION; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR FUNCTION; CATALYSIS; DIABETIC NEPHROPATHY; DNA POLYMORPHISM; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME LOCALIZATION; ENZYME MECHANISM; ENZYME REGULATION; ENZYME SPECIFICITY; ENZYME STRUCTURE; GENE; GENE DELETION; GENE OVEREXPRESSION; GLOMERULOSCLEROSIS; HEART INFARCTION; HEART VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN SENSITIVITY; ISCHEMIC CARDIOMYOPATHY; KIDNEY FUNCTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NONISCHEMIC CARDIOMYOPATHY; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; RENAL PROTECTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SEVERE ACUTE RESPIRATORY SYNDROME; TRANSCRIPTION REGULATION; UBIQUITINATION; UPREGULATION; VIRAL GENE DELIVERY SYSTEM; X CHROMOSOME;

EID: 84859871006     PISSN: 20900384     EISSN: 20900392     Source Type: Journal    
DOI: 10.1155/2012/307315     Document Type: Article

References (127)

1. Tipnis S. R., Hooper N. M., Hyde R., Karran E., Christie G., Turner A. J., A human homolog of angiotensin-converting enzyme: cloning and functional expression as a captopril-insensitive carboxypeptidase. Journal of Biological Chemistry 2000 275 43 33238 33243 2-s2.0-0034721906 10.1074/jbc.M002615200
2. Donoghue M., Hsieh F., Baronas E., Godbout K., Gosselin M., Stagliano N., Donovan M., Woolf B., Robison K., Jeyaseelan R., Breitbart R. E., Acton S., A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9. Circulation Research 2000 87 5 E1 E9 2-s2.0-0038053724
3. Vickers C., Hales P., Kaushik V., Dick L., Gavin J., Tang J., Godbout K., Parsons T., Baronas E., Hsieh F., Acton S., Patane M., Nichols A., Tummino P., Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. Journal of Biological Chemistry 2002 277 17 14838 14843 2-s2.0-18544378161 10.1074/jbc.M200581200 (Pubitemid 34952556)
4. Dales N. A., Gould A. E., Brown J. A., Calderwood E. F., Guan B., Minor C. A., Gavin J. M., Hales P., Kaushik V. K., Stewart M., Tummino P. J., Vickers C. S., Ocain T. D., Patane M. A., Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors. Journal of the American Chemical Society 2002 124 40 11852 11853 2-s2.0-0037048716 10.1021/ja0277226
5. Rushworth C. A., Guy J. L., Turner A. J., Residues affecting the chloride regulation and substrate selectivity of the angiotensin-converting enzymes (ACE and ACE2) identified by site-directed mutagenesis. FEBS Journal 2008 275 23 6033 6042 2-s2.0-55949102926 10.1111/j.1742-4658.2008.06733.x
6. Kalea A. Z., Batlle D., Apelin and ACE2 in cardiovascular disease. Current Opinion in Investigational Drugs 2010 11 3 273 282 2-s2.0-77649110591
7. Towler P., Staker B., Prasad S. G., Menon S., Tang J., Parsons T., Ryan D., Fisher M., Williams D., Dales N. A., Patane M. A., Pantoliano M. W., ACE2 X-ray structures reveal a large hinge-bending motion important for inhibitor binding and catalysis. Journal of Biological Chemistry 2004 279 17 17996 18007 2-s2.0-2342418543 10.1074/jbc.M311191200 (Pubitemid 38560569)
8. Guy J. L., Jackson R. M., Acharya K. R., Sturrock E. D., Hooper N. M., Turner A. J., Angiotensin-converting enzyme-2 (ACE2): comparative modeling of the active site, specificity requirements, and chloride dependence. Biochemistry 2003 42 45 13185 13192 2-s2.0-0242569193 10.1021/bi035268s (Pubitemid 37420671)
9. Guy J. L., Jackson R. M., Jensen H. A., Hooper N. M., Turner A. J., Identification of critical active-site residues in angiotensin-converting enzyme-2 (ACE2) by site-directed mutagenesis. FEBS Journal 2005 272 14 3512 3520 2-s2.0-22544481731 10.1111/j.1742-4658.2005.04756.x (Pubitemid 41021165)
10. Rella M., Rushworth C. A., Guy J. L., Turner A. J., Langer T., Jackson R. M., Structure-based pharmacophore design and virtual screening for novel angiotensin converting enzyme 2 inhibitors. Journal of Chemical Information and Modeling 2006 46 2 708 716 2-s2.0-33646256792 10.1021/ci0503614
11. Ferrario C. M., Jessup J., Chappell M. C., Averill D. B., Brosnihan K. B., Tallant E. A., Diz D. I., Gallagher P. E., Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2. Circulation 2005 111 20 2605 2610 2-s2.0-19644384705 10.1161/CIRCULATIONAHA.104.510461 (Pubitemid 40740859)
12. Byrnes J. J., Gross S., Ellard C., Connolly K., Donahue S., Picarella D., Effects of the ACE2 inhibitor GL1001 on acute dextran sodium sulfate-induced colitis in mice. Inflammation Research 2009 58 11 819 827 2-s2.0-70349954913 10.1007/s00011-009-0053-3
13. Warner F. J., Lew R. A., Smith A. I., Lambert D. W., Hooper N. M., Turner A. J., Angiotensin-converting enzyme 2 (ACE2), but not ACE, is preferentially localized to the apical surface of polarized kidney cells. Journal of Biological Chemistry 2005 280 47 39353 39362 2-s2.0-27944467680 10.1074/jbc.M508914200 (Pubitemid 41713892)
14. Hamming I., Timens W., Bulthuis M. L. C., Lely A. T., Navis G. J., van Goor H., Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. Journal of Pathology 2004 203 2 631 637 2-s2.0-2642539225 10.1002/path.1570 (Pubitemid 38714099)
15. Paizis G., Tikellis C., Cooper M. E., Schembri J. M., Lew R. A., Smith A. I., Shaw T., Warner F. J., Zuilli A., Burrell L. M., Angus P. W., Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2. Gut 2005 54 12 1790 1796 2-s2.0-28144453548 10.1136/gut.2004.062398 (Pubitemid 41697680)
16. Doobay M. F., Talman L. S., Obr T. D., Tian X., Davisson R. L., Lazartigues E., Differential expression of neuronal ACE2 in transgenic mice with overexpression of the brain renin-angiotensin system. American Journal of PhysiologyRegulatory Integrative and Comparative Physiology 2007 292 1 R373 R381 2-s2.0-33846183617 10.1152/ajpregu.00292.2006 (Pubitemid 46089851)
17. Xu P., Sriramula S., Lazartigues E., elazar@lsuhsc.edu ACE2/ANG-(1-7)/Mas pathway in the brain: the axis of good. American Journal of PhysiologyRegulatory Integrative and Comparative Physiology 2011 300 4 R804 R817 10.1152/ajpregu.00222.2010
18. Diz D. I., Garcia-Espinosa M. A., Gegick S., Tommasi E. N., Ferrario C. M., Tallant E. A., Chappell M. C., Gallagher P. E., Injections of angiotensin-converting enzyme 2 inhibitor MLN4760 into nucleus tractus solitarii reduce baroreceptor reflex sensitivity for heart rate control in rats. Experimental Physiology 2008 93 5 694 700 2-s2.0-42649141198 10.1113/expphysiol.2007.040261 (Pubitemid 351595065)
19. Feng Y., Xia H., Cai Y., Halabi C. M., Becker L. K., Santos R. A. S., Speth R. C., Sigmund C. D., Lazartigues E., Brain-selective overexpression of human angiotensin-converting enzyme type 2 attenuates neurogenic hypertension. Circulation Research 2010 106 2 373 382 2-s2.0-76349095332 10.1161/CIRCRESAHA. 109.208645
20. Xia H., Feng Y., Obr T. D., Hickman P. J., Lazartigues E., Angiotensin II type 1 receptor-mediated reduction of angiotensin-converting enzyme 2 activity in the brain impairs baroreflex function in hypertensive mice. Hypertension 2009 53 2 210 216 2-s2.0-59849099636 10.1161/HYPERTENSIONAHA.108.123844
21. Lambert D. W., Yarski M., Warner F. J., Thornhill P., Parkin E. T., Smith A. I., Hooper N. M., Turner A. J., Tumor necrosis factor- α convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2). Journal of Biological Chemistry 2005 280 34 30113 30119 2-s2.0-24044444558 10.1074/jbc.M505111200 (Pubitemid 41216188)
22. Yamazato M., Yamazato Y., Sun C., Diez-Freire C., Raizada M. K., Overexpression of angiotensin-converting enzyme 2 in the rostral ventrolateral medulla causes long-term decrease in blood pressure in the spontaneously hypertensive rats. Hypertension 2007 49 4 926 931 2-s2.0-34047193877 10.1161/01.HYP.0000259942.38108.20 (Pubitemid 351664196)
23. Rentzsch B., Todiras M., Iliescu R., Popova E., Campos L. A., Oliveira M. L., Baltatu O. C., Santos R. A., Bader M., Transgenic angiotensin-converting enzyme 2 overexpression in vessels of SHRSP rats reduces blood pressure and improves endothelial function. Hypertension 2008 52 5 967 973 2-s2.0-55949126600 10.1161/HYPERTENSIONAHA.108.114322
24. Liu C. X., Hu Q., Wang Y., Zhang W., Ma Z. Y., Feng J. B., Wang R., Wang X. P., Dong B., Gao F., Zhang M. X., zmx58@yahoo.com Zhang Y., zhangyun@sdu.edu.cn Angiotensin-converting enzyme (ACE) 2 overexpression ameliorates glomerular injury in a rat model of diabetic nephropathy: a comparison with ACE inhibition. Molecular Medicine 2011 17 1-2 59 69 10.2119/molmed.2010.00111
25. Díez-Freire C., Vázquez J., de Adjounian M. F. C., Ferrari M. F. R., Yuan L., Silver X., Torres R., Raizada M. K., mraizada@phys.med.ufl. edu ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR. Physiological Genomics 2006 27 1 12 19 10.1152/physiolgenomics. 00312.2005 (Pubitemid 44511821)
26. Yamazato M., Ferreira A. J., Yamazato Y., Gene transfer of angiotensin-converting enzyme 2 in the nucleus tractus solitarius improves baroreceptor heart rate reflex in spontaneously hypertensive rats. Journal of the Renin-Angiotensin-Aldosterone System. In press 10.1177/1470320311412809
27. Phillips M. I., Sumners C., Angiotensin II in central nervous system physiology. Regulatory Peptides 1998 78 13 1 11 2-s2.0-0032583132 10.1016/S0167-0115(98)00122-0 (Pubitemid 28561511)
28. Campagnole-Santos M. J., Heringer S. B., Batista E. N., Khosla M. C., Santos R. A. S., Differential baroreceptor reflex modulation by centrally infused angiotensin peptides. American Journal of PhysiologyRegulatory Integrative and Comparative Physiology 1992 263 1 R89 R94 2-s2.0-0026632699
29. Heringer-Walther S., Batista E. N., Walther T., Khosla M. C., Santos R. A. S., Campagnole-Santos M. J., Baroreflex improvement in SHR after ACE inhibition involves angiotensin-(1-7). Hypertension 2001 37 5 1309 1314 2-s2.0-0035716936 (Pubitemid 34163587)
30. Xia H., Lazartigues E., Angiotensin-converting enzyme 2: central regulator for cardiovascular function. Current Hypertension Reports 2010 12 3 170 175 2-s2.0-77956392838 10.1007/s11906-010-0105-7
31. Crackower M. A., Sarao R., Oudit G. Y., Yagil C., Kozieradzki I., Scanga S. E., Oliveira-dos-Santos A. J., da Costa J., Zhang L., Pei Y., Scholey J., Ferrarlo C. M., Manoukian A. S., Chappell M. C., Backx P. H., Yagil Y., Penninger J. M., Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 2002 417 6891 822 828 2-s2.0-0037142101 10.1038/nature00786 (Pubitemid 34670323)
32. Danilczyk U., Penninger J. M., Angiotensin-converting enzyme II in the heart and the kidney. Circulation Research 2006 98 4 463 471 2-s2.0-33645299090 10.1161/01.RES.0000205761.22353.5f
33. Yamamoto K., Ohishi M., Katsuya T., Ito N., Ikushima M., Kaibe M., Tatara Y., Shiota A., Sugano S., Takeda S., Rakugi H., Ogihara T., Deletion of angiotensin-converting enzyme 2 accelerates pressure overload-induced cardiac dysfunction by increasing local angiotensin II. Hypertension 2006 47 4 718 726 2-s2.0-33645834948 10.1161/01.HYP.0000205833.89478.5b (Pubitemid 43740244)
34. Gurley S. B., Allred A., Le T. H., Griffiths R., Mao L., Philip N., Haystead T. A., Donoghue M., Breitbart R. E., Acton S. L., Rockman H. A., Coffman T. M., Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice. Journal of Clinical Investigation 2006 116 8 2218 2225 2-s2.0-33746724157 10.1172/JCI16980 (Pubitemid 44162331)
35. Wong D. W., Oudit G. Y., Reich H., Kassiri Z., Zhou J., Liu Q. C., Backx P. H., Penninger J. M., Herzenberg A. M., Scholey J. W., Loss of Angiotensin-converting enzyme-2 (Ace2) accelerates diabetic kidney injury. American Journal of Pathology 2007 171 2 438 451 2-s2.0-34548295365 10.2353/ajpath.2007.060977 (Pubitemid 47344677)
36. Gurley S. B., Coffman T. M., Angiotensin-converting enzyme 2 gene targeting studies in mice: mixed messages. Experimental Physiology 2008 93 5 538 542 2-s2.0-42649108055 10.1113/expphysiol.2007.040014 (Pubitemid 351595062)
37. Bodiga S., Zhong J. C., Wang W., Basu R., Lo J., Liu G. C., Guo D., Holland S. M., Scholey J. W., Penninger J. M., Kassiri Z., Oudit G. Y., gavin.oudit@ualberta.ca Enhanced susceptibility to biomechanical stress in ACE2 null mice is prevented by loss of the p47phox NADPH oxidase subunit. Cardiovascular Research 2011 91 1 151 161 10.1093/cvr/cvr036
38. Kassiri Z., Zhong J., Guo D., Basu R., Wang X., Liu P. P., Scholey J. W., Penninger J. M., Oudit G. Y., Loss of angiotensin-converting enzyme 2 accelerates maladaptive left ventricular remodeling in response to myocardial infarction. Circulation: Heart Failure 2009 2 5 446 455 2-s2.0-70350457666 10.1161/CIRCHEARTFAILURE.108.840124
39. Rice G. I., Thomas D. A., Grant P. J., Turner A. J., Hooper N. M., Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochemical Journal 2004 383 1 45 51 2-s2.0-6344246036 10.1042/BJ20040634 (Pubitemid 39389449)
40. Grobe J. L., Mecca A. P., Mao H., Katovich M. J., Chronic angiotensin-(1-7) prevents cardiac fibrosis in DOCA-salt model of hypertension. American Journal of PhysiologyHeart and Circulatory Physiology 2006 290 6 H2417 H2423 2-s2.0-33744910056 10.1152/ajpheart.01170.2005 (Pubitemid 43846070)
41. Grobe J. L., Mecca A. P., Lingis M., Shenoy V., Bolton T. A., Machado J. M., Speth R. C., Raizada M. K., Katovich M. J., Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7). American Journal of PhysiologyHeart and Circulatory Physiology 2007 292 2 H736 H742 2-s2.0-33846987938 10.1152/ajpheart.00937.2006
42. Mercure C., Yogi A., Callera G. E., Aranha A. B., Bader M., Ferreira A. J., Santos R. A. S., Walther T., Touyz R. M., Reudelhuber T. L., Angiotensin(1-7) blunts hypertensive cardiac remodeling by a direct effect on the heart. Circulation Research 2008 103 11 1319 1326 2-s2.0-58149352445 10.1161/CIRCRESAHA.108.184911
43. Tallant E. A., Ferrario C. M., Gallagher P. E., Angiotensin-(1-7) inhibits growth of cardiac myocytes through activation of the mas receptor. American Journal of PhysiologyHeart and Circulatory Physiology 2005 289 4 H1560 H1566 2-s2.0-25444473110 10.1152/ajpheart.00941.2004 (Pubitemid 41368998)
44. Qi Y., Shenoy V., Wong F., Lentiviral mediated overexpression of Angiotensin-(1-7) attenuated ischemia-induced cardiac pathophysiology. Experimental Physiology 2011 96 9 863 874 10.1113/expphysiol.2011.056994
45. Johnston C. I., Tissue angiotensin converting enzyme in cardiac and vascular hypertrophy, repair, and remodeling. Hypertension 1994 23 2 258 268 2-s2.0-0028087183
46. Passier R. C. J. J., Smits J. F. M., Verluyten M. J. A., Daemen M. J. A. P., Expression and localization of renin and angiotensinogen in rat heart after myocardial infarction. American Journal of PhysiologyHeart and Circulatory Physiology 1996 271 3 H1040 H1048 2-s2.0-0029819263
47. Silvestre J. S., Heymes C., Oubénaïssa A., Robert V., Aupetit-Faisant B., Carayon A., Swynghedauw B., Delcayre C., Activation of cardiac aldosterone production in rat myocardial infarction. Effect of angiotensin II receptor blockade and role in cardiac fibrosis. Circulation 1999 99 20 2694 2701 2-s2.0-0033602819 (Pubitemid 29237459)
48. Kittleson M. M., Minhas K. M., Irizarry R. A., Ye S. Q., Edness G., Breton E., Conte J. V., Tomaselli G., Garcia J. G. N., Hare J. M., Gene expression analysis of ischemic and nonischemic cardiomyopathy: shared and distinct genes in the development of heart failure. Physiological Genomics 2005 21 299 307 2-s2.0-21344442672 10.1152/physiolgenomics.00255.2004 (Pubitemid 40903130)
49. Goulter A. B., Goddard M. J., Allen J. C., Clark K. L., ACE2 gene expression is up-regulated in the human failing heart. BMC Medicine 2004 2 19 2-s2.0-4243105120 10.1186/1741-7015-2-19 (Pubitemid 39111859)
50. Zisman L. S., Keller R. S., Weaver B., Lin Q., Speth R., Bristow M. R., Canver C. C., Increased angiotensin-(1-7)-forming activity in failing human heart ventricles: evidence for upregulation of the angiotensin-converting enzyme homologue ACE2. Circulation 2003 108 14 1707 1712 2-s2.0-0141988865 10.1161/01.CIR.0000094734.67990.99 (Pubitemid 37243658)
51. Burrell L. M., Risvanis J., Kubota E., Dean R. G., MacDonald P. S., Lu S., Tikellis C., Grant S. L., Lew R. A., Smith A. I., Cooper M. E., Johnston C. I., Myocardial infarction increases ACE2 expression in rat and humans. European Heart Journal 2005 26 4 369 375 2-s2.0-20044377209 10.1093/eurheartj/ehi114 (Pubitemid 40283096)
52. Ocaranza M. P., Godoy I., Jalil J. E., Varas M., Collantes P., Pinto M., Roman M., Ramirez C., Copaja M., Diaz-Araya G., Castro P., Lavandero S., Enalapril attenuates downregulation of angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat. Hypertension 2006 48 4 572 578 2-s2.0-33750589885 10.1161/01.HYP.0000237862.94083.45 (Pubitemid 44843858)
53. Zhong J. C., Huang D. Y., Yang Y. M., Li Y. F., Liu G. F., Song X. H., Du K., Upregulation of angiotensin-converting enzyme 2 by all-trans retinoic acid in spontaneously hypertensive rats. Hypertension 2004 44 6 907 912 2-s2.0-9644258509 10.1161/01.HYP.0000146400.57221.74 (Pubitemid 39577420)
54. Benjafield A. V., Wang W. Y. S., Morris B. J., No association of angiotensin-converting enzyme 2 gene (ACE2) polymorphisms with essential hypertension. American Journal of Hypertension 2004 17 7 624 628 2-s2.0-3042596693 10.1016/j.amjhyper.2004.02.022 (Pubitemid 38844990)
55. Tikellis C., Cooper M. E., Bialkowski K., Johnston C. I., Burns W. C., Lew R. A., Smith A. I., Thomas M. C., Developmental expression of ACE2 in the SHR kidney: a role in hypertension? Kidney International 2006 70 1 34 41 2-s2.0-33745725913 10.1038/sj.ki.5000428 (Pubitemid 44000118)
56. Wakahara S., Konoshita T., Mizuno S., Motomura M., Aoyama C., Makino Y., Kato N., Koni I., Miyamori I., Synergistic expression of angiotensin-converting enzyme (ACE) and ACE2 in human renal tissue and confounding effects of hypertension on the ACE to ACE2 ratio. Endocrinology 2007 148 5 2453 2457 2-s2.0-34249774906 10.1210/en.2006-1287 (Pubitemid 46997072)
57. Konoshita T., Wakahara S., Mizuno S., Motomura M., Aoyama C., Makino Y., Kawai Y., Kato N., Koni I., Miyamori I., Mabuchi H., Tissue gene expression of renin-angiotensin system in human type 2 diabetic nephropathy. Diabetes Care 2006 29 4 848 852 2-s2.0-33746368725 (Pubitemid 44115305)
58. Ye M., Wysocki J., William J., Soler M. J., Cokic I., Batlle D., Glomerular localization and expression of angiotensin-converting enzyme 2 and angiotensin-converting enzyme: implications for albuminuria in diabetes. Journal of the American Society of Nephrology 2006 17 11 3067 3075 2-s2.0-33750722109 10.1681/ASN.2006050423 (Pubitemid 44707767)
59. Wysocki J., Ye M., Soler M. J., Gurley S. B., Xiao H. D., Bernstein K. E., Coffman T. M., Chen S., Batlle D., ACE and ACE2 activity in diabetic mice. Diabetes 2006 55 7 2132 2139 2-s2.0-33747052918 10.2337/db06-0033 (Pubitemid 44509989)
60. Tikellis C., Johnston C. I., Forbes J. M., Burns W. C., Burrell L. M., Risvanis J., Cooper M. E., Characterization of renal angiotensinconverting enzyme 2 in diabetic nephropathy. Hypertension 2003 41 3 392 397 2-s2.0-0037341501 10.1161/01.HYP.0000060689.38912.CB (Pubitemid 36314606)
61. Lely A. T., Hamming I., van Goor H., Navis G. J., Renal ACE2 expression in human kidney disease. Journal of Pathology 2004 204 5 587 593 2-s2.0-8344230109 10.1002/path.1670 (Pubitemid 39585958)
62. Mizuiri S., Hemmi H., Arita M., Ohashi Y., Tanaka Y., Miyagi M., Sakai K., Ishikawa Y., Shibuya K., Hase H., Aikawa A., Expression of ACE and ACE2 in individuals with diabetic kidney disease and healthy controls. American Journal of Kidney Diseases 2008 51 4 613 623 2-s2.0-40849127119 10.1053/j.ajkd.2007.11. 022 (Pubitemid 351400834)
63. Oudit G. Y., Herzenberg A. M., Kassiri Z., Wong D., Reich H., Khokha R., Crackower M. A., Backx P. H., Penninger J. M., Scholey J. W., Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis. American Journal of Pathology 2006 168 6 1808 1820 2-s2.0-33744731510 10.2353/ajpath.2006.051091 (Pubitemid 43825302)
64. Soler M. J., Wysocki J., Ye M., Lloveras J., Kanwar Y., Batlle D., ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice. Kidney International 2007 72 5 614 623 2-s2.0-34548153521 10.1038/sj.ki.5002373 (Pubitemid 47312795)
65. Tikellis C., Bialkowski K., Pete J., Sheehy K., Su Q., Johnston C., Cooper M. E., Thomas M. C., ACE2 deficiency modifies renoprotection afforded by ACE inhibition in experimental diabetes. Diabetes 2008 57 4 1018 1025 2-s2.0-42449140640 10.2337/db07-1212
66. Shao Y., He M., Zhou L., Yao T., Huang Y., Lu L. M., Chronic angiotensin (1-7) injection accelerates STZ-induced diabetic renal injury. Acta Pharmacologica Sinica 2008 29 7 829 837 2-s2.0-58149243501 10.1111/j.1745-7254. 2008.00812.x
67. Santos R. A. S., Silva A. C. S., Maric C., Silva D. M. R., Machado R. P., de Buhr I., Heringer-Walther S., Pinheiro S. V. B., Lopes M. T., Bader M., Mendes E. P., Lemos V. S., Campagnole-Santos M. J., Schultheiss H. P., Speth R., Walther T., Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proceedings of the National Academy of Sciences of the United States of America 2003 100 14 8258 8263 2-s2.0-0037478671 10.1073/pnas. 1432869100 (Pubitemid 36842532)
68. Tikellis C., Wookey P. J., Candido R., Andrikopoulos S., Thomas M. C., Cooper M. E., Improved islet morphology after blockade of the renin-angiotensin system in the ZDF rat. Diabetes 2004 53 4 989 997 2-s2.0-1842475446 10.2337/diabetes.53.4.989 (Pubitemid 38436611)
69. Bindom S. M., Lazartigues E., The sweeter side of ACE2: physiological evidence for a role in diabetes. Molecular and Cellular Endocrinology 2009 302 2 193 202 2-s2.0-62949127898 10.1016/j.mce.2008.09.020
70. Zhang Y., Wada J., Yasuhara A., Iseda I., Eguchi J., Fukui K., Yang Q., Yamagata K., Hiesberger T., Igarashi P., Zhang H., Wang H., Akagi S., Kanwar Y. S., Makino H., The role for HNF-1 β -targeted collectrin in maintenance of primary cilia and cell polarity in collecting duct cells. PLoS ONE 2007 2 5 e414 2-s2.0-34547859121 10.1371/journal.pone.0000414
71. Fukui K., Yang Q., Cao Y., Takahashi N., Hatakeyama H., Wang H., Wada J., Zhang Y., Marselli L., Nammo T., Yoneda K., Onishi M., Higashiyama S., Matsuzawa Y., Gonzalez F. J., Weir G. C., Kasai H., Shimomura I., Miyagawa J. I., Wollheim C. B., Yamagata K., The HNF-1 target collectrin controls insulin exocytosis by SNARE complex formation. Cell Metabolism 2005 2 6 373 384 2-s2.0-33644878503 10.1016/j.cmet.2005.11.003
72. Yasuhara A., Wada J., Malakauskas S. M., Zhang Y., Eguchi J., Nakatsuka A., Murakami K., Kanzaki M., Teshigawara S., Yamagata K., Le T. H., Makino H., Collectrin is involved in the development of salt-sensitive hypertension by facilitating the membrane trafficking of apical membrane proteins via interaction with soluble N-ethylmaleiamide-sensitive factor attachment protein receptor complex. Circulation 2008 118 21 2146 2155 2-s2.0-57449121575 10.1161/CIRCULATIONAHA.108.787259
73. Malakauskas S. M., Kourany W. M., Xiao Y. Z., Lu D., Stevens R. D., Koves T. R., Hohmeier H. E., Muoio D. M., Newgard C. B., Le T. H., Increased insulin sensitivity in mice lacking collectrin, a downstream target of HNF-1 α Molecular Endocrinology 2009 23 6 881 892 2-s2.0-66449113721 10.1210/me.2008-0274
74. Danilczyk U., Sarao R., Remy C., Benabbas C., Stange G., Richter A., Arya S., Pospisilik J. A., Singer D., Camargo S. M. R., Makrides V., Ramadan T., Verrey F., Wagner C. A., Penninger J. M., Essential role for collectrin in renal amino acid transport. Nature 2006 444 7122 1088 1091 2-s2.0-33845864984 10.1038/nature05475 (Pubitemid 46018530)
75. Malakauskas S. M., Quan H., Fields T. A., McCall S. J., Yu M. J., Kourany W. M., Frey C. W., Le T. H., Aminoaciduria and altered renal expression of luminal amino acid transporters in mice lacking novel gene collectrin. American Journal of PhysiologyRenal Physiology 2007 292 2 F533 F544 2-s2.0-33846883761 10.1152/ajprenal.00325.2006 (Pubitemid 46220520)
76. Kowalczuk S., Bröer A., Tietze N., Vanslambrouck J. M., Rasko J. E. J., Bröer S., A protein complex in the brush-border membrane explains a Hartnup disorder allele. FASEB Journal 2008 22 8 2880 2887 2-s2.0-48749084616 10.1096/fj.08-107300
77. Li W., Moore M. J., Vasllieva N., Sui J., Wong S. K., Berne M. A., Somasundaran M., Sullivan J. L., Luzuriaga K., Greeneugh T. C., Choe H., Farzan M., Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 2003 426 6965 450 454 2-s2.0-0344395657 10.1038/nature02145 (Pubitemid 37490132)
78. Li F., Li W., Farzan M., Harrison S. C., Structural biology: structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science 2005 309 5742 1864 1868 2-s2.0-24944498409 10.1126/science.1116480 (Pubitemid 41325098)
79. Kuba K., Imai Y., Rao S., Gao H., Guo F., Guan B., Huan Y., Yang P., Zhang Y., Deng W., Bao L., Zhang B., Liu G., Wang Z., Chappell M., Liu Y., Zheng D., Leibbrandt A., Wada T., Slutsky A. S., Liu D., Qin C., Jiang C., Penninger J. M., A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nature Medicine 2005 11 8 875 879 2-s2.0-23844463115 10.1038/nm1267 (Pubitemid 41161120)
80. Imai Y., Kuba K., Rao S., Huan Y., Guo F., Guan B., Yang P., Sarao R., Wada T., Leong-Poi H., Crackower M. A., Fukamizu A., Hui C. C., Hein L., Uhlig S., Slutsky A. S., Jiang C., Penninger J. M., Angiotensin-converting enzyme 2 protects from severe acute lung failure. Nature 2005 436 7047 112 116 2-s2.0-21844460785 10.1038/nature03712 (Pubitemid 40966195)
81. Glowacka I., Bertram S., Herzog P., Pfefferle S., Steffen I., Muench M. O., Simmons G., Hofmann H., Kuri T., Weber F., Eichler J., Drosten C., Pöhlmann S., Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63. Journal of Virology 2010 84 2 1198 1205 2-s2.0-73849149813 10.1128/JVI.01248-09
82. Koka V., Xiao R. H., Chung A. C. K., Wang W., Truong L. D., Lan H. Y., Angiotensin II up-regulates angiotensin I-converting enzyme (ACE), but down-regulates ACE2 via the AT1-ERK/p38 MAP kinase pathway. American Journal of Pathology 2008 172 5 1174 1183 2-s2.0-43449084360 10.2353/ajpath.2008.070762 (Pubitemid 351671532)
83. Yamamuro M., Yoshimura M., Nakayama M., Abe K., Sumida H., Sugiyama S., Saito Y., Nakao K., Yasue H., Ogawa H., Aldosterone, but not angiotensin II, reduces angiotensin converting enzyme 2 gene expression levels in cultured neonatal rat cardiomyocytes. Circulation Journal 2008 72 8 1346 1350 2-s2.0-48749108107 10.1253/circj.72.1346
84. Gallagher P. E., Ferrario C. M., Tallant E. A., MAP kinase/phosphatase pathway mediates the regulation of ACE2 by angiotensin peptides. American Journal of PhysiologyCell Physiology 2008 295 5 C1169 C1174 2-s2.0-56649122620 10.1152/ajpcell.00145.2008 (Pubitemid 352790330)
85. Zhong J. C., Ye J. Y., Jin H. Y., Yu X., Yu H. M., Zhu D. L., Gao P. J., Huang D. Y., Shuster M., Loibner H., Guo J. M., Yu X. Y., Xiao B. X., Gong Z. H., Penninger J. M., Oudit G. Y., Telmisartan attenuates aortic hypertrophy in hypertensive rats by the modulation of ACE2 and profilin-1 expression. Regulatory Peptides 2011 166 13 90 97 2-s2.0-78650170861 10.1016/j.regpep.2010. 09.005
86. Jessup J. A., Gallagher P. E., Averill D. B., Brosnihan K. B., Tallant E. A., Chappell M. C., Ferrario C. M., Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats. American Journal of Physiology Heart Circirculation Physiology 2006 291 5 H2166 H2172 2-s2.0-57349151583 10.1152/ajpheart.00061.2006
87. Huang M. L., Li X., Meng Y., Xiao B., Ma Q., Ying S. S., Wu P. S., Zhang Z. S., Upregulation of angiotensin-converting enzyme (ACE) 2 in hepatic fibrosis by ACE inhibitors. Clinical and Experimental Pharmacology and Physiology 2010 37 1 e1 e6 2-s2.0-74049134978 10.1111/j.1440-1681.2009.05302.x
88. Zhang R., Wu Y., Zhao M., Liu C., Zhou L., Shen S., Liao S., Yang K., Li Q., Wan H., Role of HIF-1 α in the regulation ACE and ACE2 expression in hypoxic human pulmonary artery smooth muscle cells. American Journal of PhysiologyLung Cellular and Molecular Physiology 2009 297 4 L631 L640 2-s2.0-70349774464 10.1152/ajplung.90415.2008
89. Tan Z., Wu J., Ma H., Regulation of angiotensin-converting enzyme 2 and Mas receptor by Ang-(1-7) in heart and kidney of spontaneously hypertensive rats. Journal of the Renin-Angiotensin-Aldosterone System. In press 10.1177/1470320311402109
90. Gallagher P. E., Ferrario C. M., Tallant E. A., Regulation of ACE2 in cardiac myocytes and fibroblasts. American Journal of PhysiologyHeart and Circulatory Physiology 2008 295 6 H2373 H2379 2-s2.0-57349151583 10.1152/ajpheart.00426.2008
91. Shenoy V., Grobe J. L., Qi Y., Ferreira A. J., Fraga-Silva R. A., Collamat G., Bruce E., Katovich M. J., 17 β -Estradiol modulates local cardiac renin-angiotensin system to prevent cardiac remodeling in the DOCA-salt model of hypertension in rats. Peptides 2009 30 12 2309 2315 2-s2.0-70449632336 10.1016/j.peptides.2009.09.005
92. Stewart J. A., Cashatt D. O., Borck A. C., Brown J. E., Carver W. E., 17 β -estradiol modulation of angiotensin II-stimulated response in cardiac fibroblasts. Journal of Molecular and Cellular Cardiology 2006 41 1 97 107 2-s2.0-33745353771 10.1016/j.yjmcc.2006.04.019 (Pubitemid 43946972)
93. Gálvez-Prieto B., Bolbrinker J., Stucchi P., de las Heras A. I., Merino B., Arribas S., Ruiz-Gayo M., Huber M., Wehland M., Kreutz R., Fernandez-Alfonso M. S., Comparative expression analysis of the reninangiotensin system components between white and brown perivascular adipose tissue. Journal of Endocrinology 2008 197 1 55 64 2-s2.0-42449095968 10.1677/JOE-07-0284 (Pubitemid 351566925)
94. Gupte M., Boustany-Kari C. M., Bharadwaj K., Police S., Thatcher S., Gong M. C., English V. L., Cassis L. A., ACE2 is expressed in mouse adipocytes and regulated by a high-fat diet. American Journal of PhysiologyRegulatory Integrative and Comparative Physiology 2008 295 3 R781 R788 2-s2.0-54049109974 10.1152/ajpregu.00183.2008
95. Coelho M. S., Lopes K. L., Freitas R. D. A., de Oliveira-Sales E. B., Bergasmaschi C. T., Campos R. R., Casarini D. E., Carmona A. K., Araújo M. D. S., Heimann J. C., Dolnikoff M. S., High sucrose intake in rats is associated with increased ACE2 and angiotensin-(1-7) levels in the adipose tissue. Regulatory Peptides 2010 162 13 61 67 2-s2.0-77952672185 10.1016/j.regpep.2010.03.008
96. Iwata M., Enciso J. E. S., Greenberg B. H., Selective and specific regulation of ectodomain shedding of angiotensin-converting enzyme 2 by tumor necrosis factor α -converting enzyme. American Journal of PhysiologyCell Physiology 2009 297 5 C1318 C1329 2-s2.0-70449625416 10.1152/ajpcell.00036.2009
97. Jia H. P., Look D. C., Tan P., Shi L., Hickey M., Gakhar L., Chappell M. C., Wohlford-Lenane C., McCray P. B., Ectodomain shedding of angiotensin converting enzyme 2 in human airway epithelia. American Journal of PhysiologyLung Cellular and Molecular Physiology 2009 297 1 L84 L96 2-s2.0-67650081069 10.1152/ajplung.00071.2009
98. Lai Z. W., Hanchapola I., Steer D. L., Smith A. I., ian.smith@monash.edu Angiotensin-converting enzyme 2 ectodomain shedding cleavage-site identification: determinants and constraints. Biochemistry 2011 50 23 5182 5194 10.1021/bi200525y
99. Lambert D. W., Clarke N. E., Hooper N. M., Turner A. J., Calmodulin interacts with angiotensin-converting enzyme-2 (ACE2) and inhibits shedding of its ectodomain. FEBS Letters 2008 582 2 385 390 2-s2.0-38049005632 10.1016/j.febslet.2007.11.085
100. Epelman S., Shrestha K., Troughton R. W., Francis G. S., Sen S., Klein A. L., Tang W. H. W., Soluble angiotensin-converting enzyme 2 in human heart failure: relation with myocardial function and clinical outcomes. Journal of Cardiac Failure 2009 15 7 565 571 2-s2.0-68849105984 10.1016/j.cardfail.2009.01. 014
101. Lew R. A., Warner F. J., Hanchapola I., Yarski M. A., Manohar J., Burrell L. M., Smith A. I., Angiotensin-converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitor. Experimental Physiology 2008 93 5 685 693 2-s2.0-42649095968 10.1113/expphysiol.2007.040352 (Pubitemid 351595050)
102. Oudit G. Y., Kassiri Z., Jiang C., Liu P. P., Poutanen S. M., Penninger J. M., Butany J., SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS. European Journal of Clinical Investigation 2009 39 7 618 625 2-s2.0-66849134954 10.1111/j.1365-2362.2009.02153.x
103. Haga S., Yamamoto N., Nakai-Murakami C., Osawa Y., Tokunaga K., Sata T., Yamamoto N., Sasazuki T., Ishizaka Y., Modulation of TNF- α -converting enzyme by the spike protein of SARS-CoV and ACE2 induces TNF- α production and facilitates viral entry. Proceedings of the National Academy of Sciences of the United States of America 2008 105 22 7809 7814 2-s2.0-45549097784 10.1073/pnas.0711241105 (Pubitemid 351872720)
104. Haga S., Nagata N., Okamura T., Yamamoto N., Sata T., Yamamoto N., Sasazuki T., Ishizaka Y., TACE antagonists blocking ACE2 shedding caused by the spike protein of SARS-CoV are candidate antiviral compounds. Antiviral Research 2010 85 3 551 555 2-s2.0-76949096430 10.1016/j.antiviral.2009.12.001
105. Inoue Y., Tanaka N., Tanaka Y., Inoue S., Morita K., Zhuang M., Hattori T., Sugamura K., Clathrin-dependent entry of severe acute respiratory syndrome coronavirus into target cells expressing ACE2 with the cytoplasmic tail deleted. Journal of Virology 2007 81 16 8722 8729 2-s2.0-34547743810 10.1128/JVI.00253-07 (Pubitemid 47242845)
106. Grobe J. L., der Sarkissian S., Stewart J. M., Meszaros J. G., Raizada M. K., Katoyich M. J., ACE2 overexpression inhibits hypoxia-induced collagen production by cardiac fibroblasts. Clinical Science 2007 113 7-8 357 364 2-s2.0-34648826015 10.1042/CS20070160 (Pubitemid 47572276)
107. Prada J. A. H., Ferreira A. J., Katovich M. J., Shenoy V., Qi Y., Santos R. A. S., Castellano R. K., Lampkins A. J., Gubala V., Ostrov D. A., Raizada M. K., Structure-based identification of small-molecule angiotensin-converting enzyme 2 activators as novel antihypertensive agents. Hypertension 2008 51 5 1312 1317 2-s2.0-42349105833 10.1161/HYPERTENSIONAHA.107.108944 (Pubitemid 351555943)
108. Wysocki J., Ye M., Rodriguez E., González-Pacheco F. R., Barrios C., Evora K., Schuster M., Loibner H., Brosnihan K. B., Ferrario C. M., Penninger J. M., Batlle D., Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension. Hypertension 2010 55 1 90 98 2-s2.0-73849101073 10.1161/HYPERTENSIONAHA.109.138420
109. Huentelman M. J., Grobe J. L., Vazquez J., Stewart J. M., Mecca A. P., Katovich M. J., Ferrario C. M., Raizada M. K., Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats. Experimental Physiology 2005 90 5 783 790 2-s2.0-26044453206 10.1113/expphysiol.2005.031096 (Pubitemid 41406067)
110. Dong B., Zhang C., Feng J. B., Zhao Y. X., Li S. Y., Yang Y. P., Dong Q. L., Deng B. P., Zhu L., Yu Q. T., Liu C. X., Liu B., Pan C. M., Song H. D., Zhang M. X., Zhang Y., zhangyun@sdu.edu.cn Overexpression of ACE2 enhances plaque stability in a rabbit model of atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 7 1270 1276 10.1161/ATVBAHA.108.164715
111. der Sarkissian S., Grobe J. L., Yuan L., Narielwala D. R., Walter G. A., Katovich M. J., Raizada M. K., Cardiac overexpression of angiotensin converting enzyme 2 protects the heart from ischemia-induced pathophysiology. Hypertension 2008 51 3 712 718 2-s2.0-39749202869 10.1161/HYPERTENSIONAHA.107.100693 (Pubitemid 351301525)
112. Zhao Y. X., Yin H. Q., Yu Q. T., Qiao Y., Dai H. Y., Zhang M. X., Zhang L., Liu Y. F., Wang L. C., Liu D. S., Deng B. P., Zhang Y. H., Pan C. M., Song H. D., Qu X., Jiang H., Liu C. X., Lu X. T., Liu B., Gao F., Dong B., ACE2 overexpression ameliorates left ventricular remodeling and dysfunction in a rat model of myocardial infarction. Human Gene Therapy 2010 21 11 1545 1554 2-s2.0-78649337583 10.1089/hum.2009.160
113. Ferreira A. J., Shenoy V., Yamazato Y., Sriramula S., Francis J., Yuan L., Castellano R. K., Ostrov D. A., Oh S. P., Katovich M. J., Raizada M. K., Evidence for angiotensin-converting enzyme 2 as a therapeutic target for the prevention of pulmonary hypertension. American Journal of Respiratory and Critical Care Medicine 2009 179 11 1048 1054 2-s2.0-66249133083 10.1164/rccm.200811-1678OC
114. Ferreira A. J., Shenoy V., Qi Y., Fraga-Silva R. A., Santos R. A.S., Katovich M. J., Raizada M. K., mraizada@phys.med.ufl.edu Angiotensin-converting enzyme 2 activation protects against hypertension-induced cardiac fibrosis involving extracellular signal-regulated kinases. Experimental Physiology 2011 96 3 287 294 10.1113/expphysiol.2010.055277
115. Fraga-Silva R. A., Sorg B. S., Wankhede M., deDeugd C., Jun J. Y., Baker M. B., Li Y., Castellano R. K., Katovich M. J., Raizada M. K., Ferreira A. J., ACE2 activation promotes antithrombotic activity. Molecular Medicine 2010 16 5-6 210 215 2-s2.0-77951955278 10.2119/molmed.2009.00160
116. Oudit G. Y., Liu G. C., Zhong J., Basu R., Chow F. L., Zhou J., Loibner H., Janzek E., Schuster M., Penninger J. M., Herzenberg A. M., Kassiri Z., Scholey J. W., Human recombinant ACE2 reduces the progression of diabetic nephropathy. Diabetes 2010 59 2 529 538 2-s2.0-77449160523 10.2337/db09-1218
117. Zhong J., Basu R., Guo D., Chow F. L., Byrns S., Schuster M., Loibner H., Wang X. H., Penninger J. M., Kassiri Z., Oudit G. Y., Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction. Circulation 2010 122 7 717 728 2-s2.0-77955981900 10.1161/CIRCULATIONAHA.110.955369
118. Zhong J., Guo D., Chen C. B., Wang W., Schuster M., Loibner H., Penninger J. M., Scholey J. W., Kassiri Z., Oudit G. Y., gavin.oudit@ualberta.ca Prevention of angiotensin II-mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2. Hypertension 2011 57 2 314 322 10.1161/HYPERTENSIONAHA.110.164244
119. Kohlstedt K., Shoghi F., Müller-Esterl W., Busse R., Fleming I., CK2 phosphorylates the angiotensin-converting enzyme and regulates its retention in the endothelial cell plasma membrane. Circulation Research 2002 91 8 749 756 2-s2.0-0037131193 10.1161/01.RES.0000038114.17939.C8 (Pubitemid 35204958)
120. Kohlstedt K., Kellner R., Busse R., Fleming I., Signaling via the angiotensin-converting enzyme results in the phosphorylation of the nonmuscle myosin heavy chain IIA. Molecular Pharmacology 2006 69 1 19 26 2-s2.0-30044434895 10.1124/mol.105.016733 (Pubitemid 43048889)
121. Kohlstedt K., Brandes R. P., Müller-Esterl W., Busse R., Fleming I., Angiotensin-converting enzyme is involved in outside-in signaling in endothelial cells. Circulation Research 2004 94 1 60 67 2-s2.0-0347600924 10.1161/01.RES.0000107195.13573.E4 (Pubitemid 38064099)
122. Kohlstedt K., Gershome C., Friedrich M., Müller-Esterl W., Alhenc-Gelas F., Busse R., Fleming I., fleming@em.uni-frankfurt.de Angiotensin-converting enzyme (ACE) dimerization is the initial step in the ACE inhibitor-induced ACE signaling cascade in endothelial cells. Molecular Pharmacology 2006 69 5 1725 1732 10.1124/mol.105.020636
123. Ignjacev-Lazich I., Kintsurashvili E., Johns C., Vitseva O., Duka A., Shenouda S., Gavras I., Gavras H., Angiotensin-converting enzyme regulates bradykinin receptor gene expression. American Journal of PhysiologyHeart and Circulatory Physiology 2005 289 5 H1814 H1820 2-s2.0-27144469289 10.1152/ajpheart.00581.2005 (Pubitemid 41507327)
124. Lucero H. A., Kintsurashvili E., Marketou M. E., Gavras H., Cell signaling, internalization, and nuclear localization of the angiotensin converting enzyme in smooth muscle and endothelial cells. Journal of Biological Chemistry 2010 285 8 5555 5568 2-s2.0-77949312041 10.1074/jbc.M109.074740
125. Lichtenthaler S. F., Haass C., christian.haass@med.uni-muenchen.de Steiner H., Regulated intramembrane proteolysislessons from amyloid precursor protein processing. Journal of Neurochemistry 2011 117 5 779 796 10.1111/j.1471-4159.2011.07248.x
126. Cao X., Südhof T. C., A transcriptivety active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 2001 293 5527 115 120 10.1126/science.1058783 (Pubitemid 32625507)
127. Takahashi Y., ytakahas@hosp.ncgm.go.jp Haga S., shihaga@ri.imcj.go.jp Ishizaka Y., zakay@ri.imcj.go.jp Mimori A., amimori@hosp.ncgm.go.jp Autoantibodies to angiotensin-converting enzyme 2 in patients with connective tissue diseases. Arthritis Research and Therapy 2010 12 3 R85 10.1186/ar3013